FOSTER CITY, Calif.--(BUSINESS WIRE)--Apr. 30, 2015--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s
Board of Directors has declared a quarterly cash dividend of $0.43 per
share of common stock, to be paid on the payment date of June 29, 2015
to all stockholders of record as of the close of business on the record
date of June 16, 2015. This is the first quarterly dividend declared
under the Board's dividend program announced on February 3, 2015. Future
dividends will be subject to Board approval.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.Patrick O’Brien, 650-522-1936Investor
Relations
